指南与共识其他结缔组织病类风湿关节炎脊柱关节炎

儿童关节炎与风湿病研究联盟共识治疗方案:迈向儿童风湿病比较有效性研究

The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases.
指南 / 共识 · Arthritis Rheumatol · 2018-03-31

儿童风湿病是一组异质性罕见病,传统临床与转化研究方法应用面临挑战。儿童关节炎与风湿病研究联盟(CARRA)通过共识方法制定共识治疗方案(CTP),旨在减少治疗差异、标准化结局测量并比较不同方案的有效性。目前已发布8种疾病及疾病表现的CTP,并在幼年局限性硬皮病、全身型幼年特发性关节炎(JIA)、多关节型JIA、皮肌炎和狼疮性肾炎中成功试点。

要点

  • CARRA通过共识方法制定CTP,旨在减少治疗差异、标准化结局测量并比较不同方案有效性。
  • CTP已覆盖8种疾病及疾病表现,并在5种儿童风湿病中成功试点。
  • 全身型JIA和多关节型JIA的大规模研究正在进行,以CARRA患者登记库为数据收集平台。

核心结论

  • CTP方法作为儿童风湿病比较有效性研究工具,旨在减少治疗差异、标准化结局测量并比较不同方案的有效性,以改善疾病结局。

研究设计与样本

  • CARRA成员通过共识方法制定CTP,作为儿童风湿病学研究的比较有效性工具。
  • CTP已在8种不同疾病及疾病表现中发布,并在幼年局限性硬皮病、全身型JIA、多关节型JIA、皮肌炎和狼疮性肾炎中成功试点。
  • 全身型JIA和多关节型JIA的大规模研究正在进行,以CARRA患者登记库为数据收集平台。

主要发现

  • CTP已成功试点于幼年局限性硬皮病、全身型JIA、多关节型JIA、皮肌炎和狼疮性肾炎。
  • 全身型JIA和多关节型JIA的大规模研究正在进行,以CARRA患者登记库为数据收集平台。
  • 这些研究设计包含利益相关者参与,包括CARRA提供者、患者和家长的积极投入,旨在提高可行性并确保结局的相关性。
  • 这些研究包括辅助生物标本采集,旨在支持额外的转化和机制研究。

关键数值与推荐

  • CTP已发布于8种不同疾病及疾病表现。
  • CTP试点疾病包括幼年局限性硬皮病、全身型JIA、多关节型JIA、皮肌炎和狼疮性肾炎。
  • 全身型JIA和多关节型JIA的大规模研究正在进行中。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The pediatric rheumatic diseases are a heterogeneous group of rare diseases, posing a number of challenges for the use of traditional clinical and translational research methods. Innovative comparative effectiveness approaches are needed to efficiently study treatment strategies and disease outcomes. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) developed the consensus treatment plan (CTP) approach as a comparative effectiveness tool for research in pediatric rheumatology. CTPs are treatment strategies, developed by consensus methods among CARRA members, intended to reduce variation in treatment approaches, standardize outcome measurements, and allow for comparison of the effectiveness of different approaches with the goal of improving disease outcomes. To date, CTPs have been published for 8 different diseases and disease manifestations. The approach has been successfully piloted for juvenile localized scleroderma, systemic juvenile idiopathic arthritis (JIA), polyarticular JIA, dermatomyositis, and lupus nephritis. Large-scale studies are underway for systemic JIA and polyarticular JIA, with the CARRA patient registry serving as the data collection platform. These studies have been designed with stakeholder involvement, including active input from CARRA providers, patients, and parents, with the goal of increasing feasibility and ensuring the relevance of the outcomes. These studies include ancillary biologic specimen collection intended to support additional translational and mechanistic studies. Data from these ongoing CTP studies will provide more information on the ability of this approach to identify effective treatment strategies and improve outcomes in the pediatric rheumatic diseases.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Ringold S, Nigrovic PA, Feldman BM, et al. The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases. Arthritis Rheumatol. 2018. PMID: 29333701. doi:10.1002/art.40395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。